- Home
- / Hepion Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hepion Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.6
2024-10-29
Market Capitalization
$3.8 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 1.4M | 5.6M | 5.8M | 7.4M | 7.0M | 4.6M | 8.1M | 10.0M | 10.3M | 9.6M | 7.5M | 3.3M |
| Operating expense total | 1.7M | 14.0M | 20.8M | 21.0M | 14.6M | 7.8M | 20.1M | 43.6M | 19.3M | 3.8M | ||
| EBIT | (1.7M) | (14.0M) | (20.8M) | (21.0M) | (14.6M) | (7.8M) | (20.1M) | (30.4M) | (45.5M) | (48.4M) | (19.3M) | (4.2M) |
| Interest expense | 3.6M | 387.9K | 3.8M | 4.2M | 10.2K | 9.5K | 1.2M | 24.4K | ||||
| Pre tax profit | (17.0M) | (16.8M) | (10.0M) | (7.9M) | (20.3M) | (32.7M) | (45.1M) | (49.3M) | (16.2M) | (8.3M) | ||
| Income tax expense | (1.9M) | (536.0K) | (1.2M) | 30.6K | (2.9M) | (400.0K) | (3.0M) | |||||
| Net Income | (5.3M) | (14.3M) | (17.0M) | (14.9M) | (9.4M) | (6.7M) | (20.4M) | (32.7M) | (42.2M) | (48.9M) | (13.2M) | (8.3M) |
| EPS | (0.6) | (12.0) | (107.3) | (0.9) |